New Mexico Cancer Care Alliance

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 2002-01-01

Employees: 11

Market Cap: -

Website: https://nmcca.org

Clinical Trials

Omega-3 Fatty Acid in Treating Pain in Patients With Breast or Ovarian Cancer Receiving Paclitaxel

Not Applicable

Completed

Conditions: Ovarian Neoplasm
Breast Cancer
Pain

Interventions: Dietary Supplement: Placebo
Dietary Supplement: Omega-3 fatty acid
Drug: Paclitaxel

First Posted Date: 2013-04-01

Last Posted Date: 2022-10-05

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 60

Registration Number: NCT01821833

Locations: 🇺🇸
Presbyterian Medical Group, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico Comprehensive Cancer Center, Albuquerque, New Mexico, United States

Pelvic Floor Muscle Training in Treating Urinary Incontinence in Gynecologic Cancer Survivors

Not Applicable

Completed

Conditions: Endometrial Cancer
Uterine Sarcoma
Vulvar Cancer
Ovarian Epithelial Cancer
Ovarian Germ Cell Tumor
Cervical Cancer

Interventions: Other: questionnaire administration
Procedure: standard follow-up care
Other: educational intervention

First Posted Date: 2013-03-07

Last Posted Date: 2013-03-07

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 40

Registration Number: NCT01806350

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Feasibility of Thioridazine as a Mobilizing Agent for CD34+ Hematopoietic Progenitor Cells

Early Phase 1

Terminated

Conditions: Healthy Subjects

Interventions: Drug: Mellaril

First Posted Date: 2013-01-10

Last Posted Date: 2016-04-14

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 6

Registration Number: NCT01765803

Locations: 🇺🇸
University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States

IR-guided Ablation (IRGA) Combined With Stereotactic Ablative Radiation (SABR) for Large Lung Tumors

Phase 1

Terminated

Conditions: Recurrent Non-small Cell Lung Cancer

Interventions: Radiation: Stereotactic body RT and IRGA

First Posted Date: 2012-12-11

Last Posted Date: 2017-11-17

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 1

Registration Number: NCT01746810

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Early Phase 1

Completed

Conditions: Fallopian Tube Cancer
Peritoneal Cavity Cancer
Ovarian Cancer

Interventions: Drug: Ketorolac

First Posted Date: 2012-08-22

Last Posted Date: 2020-02-27

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 29

Registration Number: NCT01670799

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Irinotecan for Previously Treated, Advanced, Non-Small Cell Lung Cancer

Phase 1

Terminated

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Irinotecan

First Posted Date: 2012-05-30

Last Posted Date: 2018-05-22

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 2

Registration Number: NCT01607554

Locations: 🇺🇸
New Mexico Cancer Care Associates, Santa Fe, New Mexico, United States
🇺🇸
Hematology Oncology Associates, Albuquerque, New Mexico, United States
🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

Phase 1

Terminated

Conditions: Cancer, Metastatic

Interventions: Drug: Carboplatin
Drug: Pazopanib

First Posted Date: 2012-03-01

Last Posted Date: 2015-06-18

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 3

Registration Number: NCT01542047

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Metformin With Standard Taxotere and Prednisone in the Treatment of Castration Resistant Prostate Cancer

Phase 2

Withdrawn

Conditions: Prostate Cancer

First Posted Date: 2011-11-23

Last Posted Date: 2013-03-06

Lead Sponsor: New Mexico Cancer Care Alliance

Registration Number: NCT01478308

Pilot Study of Raltegravir and Cisplatin in Squamous Cell Carcinoma of Head and Neck

Early Phase 1

Completed

Conditions: Head and Neck Cancer

Interventions: Drug: raltegravir and cisplatin

First Posted Date: 2011-01-12

Last Posted Date: 2015-06-18

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 5

Registration Number: NCT01275183

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

Study of Revlimid With Doxil and Avastin for Patients With Platinum Resistant Ovarian Cancer

Phase 1

Terminated

Conditions: Ovarian Cancer
Epithelial Ovarian Cancer
Fallopian Tube Carcinoma
Primary Peritoneal Carcinoma

Interventions: Drug: Lenalidomide, Liposomal Doxorubicin, Bevacizumab
Drug: Revlimid, Doxil, Avastin

First Posted Date: 2010-09-16

Last Posted Date: 2014-01-08

Lead Sponsor: New Mexico Cancer Care Alliance

Target Recruit Count: 1

Registration Number: NCT01202890

Locations: 🇺🇸
University of New Mexico Cancer Center, Albuquerque, New Mexico, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy